Wynzora calcipotriene and betamethasone dipropionate 0.005%/0.064% cream Images

Generic Name: betamethasone/calcipotriene

This medication has been identified as Wynzora calcipotriene and betamethasone dipropionate 0.005%/0.064% cream. It is supplied by MC2 Therapeutics, Inc.

Wynzora is used in the treatment of Plaque Psoriasis; Psoriasis and belongs to the drug class topical antipsoriatics. Risk cannot be ruled out during pregnancy. Wynzora calcipotriene and betamethasone dipropionate 0.005%/0.064% cream is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Wynzora

Generic Name

betamethasone/calcipotriene

Strength

calcipotriene and betamethasone dipropionate 0.005%/0.064% cream

Availability

Prescription only

Drug Class

Topical antipsoriatics

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

MC2 Therapeutics, Inc.

National Drug Code (NDC)

73499-0001

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer